Health leaders of tomorrow - the inaugural cohort of the INEOS Oxbridge Doctoral Initiative on Antimicrobial Resistance
The INEOS Oxbridge Doctoral Initiative on antimicrobial resistance is the flagship PhD programme of the Ineos Oxford Institute (IOI).
Designed to harness the combined expertise of two world-leading universities, Oxford and Cambridge, the initiative nurtures the next generation of scientific leaders to combat the threat of antimicrobial resistance (AMR).
The first cohort of students began their 4-year PhD projects from October 2023, and are co-supervised by professors at the universities of Cambridge and Oxford. Students are encouraged to spend time in both universities to learn new skills and expand their network of AMR collaborators.
The inaugural meeting brought the first cohort together for the first time, providing space for networking and stimulating discussion about each of their projects.
The second cohort of students will begin their PhD projects in October 2023, which span multiple disciplines from health economics, public health, engineering and medical sciences.